Jerry is much more than proud. He put $500K loan of his own monies into an available cash pool for Elite to draw from for new projects related to the new patent ELI-216 8,182,836 issued on May 22, 2012. These new projects are obviously contracted by outsiders interested in applying ELI-216 pharmacological properties to their potential opioids products.